arrow
Return

Armodafinil

delete2009-09-01
delete44
PRE
AI
K
Karly P. Garnock-Jones *
S
Sohita Dhillon
L
Lesley J. Scott
DOI:10.2165/11203290-000000000-00000delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Armodafinil is the R-enantiomer of modafinil, a wake-promoting agent, that primarily affects areas of the brain involved in controlling wakefulness. Once-daily armodafinil was effective in improving wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome (OSA) [despite treatment of the underlying condition], narcolepsy or shift work sleep disorder (SWSD) in four large (n > 195), double-blind, multinational trials of 12 weeks' duration. Compared with placebo, mean sleep latency (coprimary endpoint) was significantly improved with armodafinil 150 or 250 mg once daily in patients with OSA or narcolepsy, and with armodafinil 150 mg once daily in patients with SWSD, as assessed by the Multiple Sleep Latency Test (MSLT) or the Maintenance of Wakefulness Test (MWT). Furthermore, a significantly higher proportion of armodafinil than placebo recipients achieved a response (at least a minimal improvement) on the Clinical Global Impressions of Change (CGI-C) scale at study end in these four trials (coprimary endpoint). Once-daily armodafinil was generally well tolerated in adult patients with excessive sleepiness associated with OSA (despite treatment of the underlying condition), narcolepsy or SWSD.
Keywords:
WORK SLEEP DISORDER
HEALTHY-SUBJECTS
DOUBLE-BLIND
PHARMACOKINETIC PROFILE
APNEA/HYPOPNEA SYNDROME
MODAFINIL TABLETS
ADULTS
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

CNS Drugs cover
CNS Drugs
IF:
7.4
Papers:
2.5K
Citations:
7.0K

Organization

A
adis international
Scholars:
102
Papers: 386
Citations: 0
Cited Papers

Cited Papers

Averaged evoked myogenic responses in normal man
err2009-01-05
err0
PREAI
errD. Thane R. Cody; Reginald G. Bickford
errShare
errSave
Armodafinil promotes wakefulness and activates Fos in rat brain
err2009-05-01
err15
PREAI
errFiocchi, Elaine M.; Lin, Yin-Guo; Aimone, Lisa; Gruner, John A.; Flood, Dorothy G.
errShare
errSave
Regionalisation of anterior neuroectoderm and its competence in responding to forebrain and midbrain inducing activities depend on mutual antagonism between OTX2 and GBX2
err2001-12-01
err0
errOAAI
errJuan Pedro Martinez-Barbera; Massimo Signore; Pietro Pilo Boyl; Eduardo Puelles; Dario Acampora; Robin Gogoi; Frank Schubert; Andrew Lumsden; Antonio Simeone
errShare
errSave
Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome
err2007-03-01
err101
errOAAI
errHirshkowitz, M.; Black, J. E.; Wesnes, K.; Niebler, G.; Arora, S.; Roth, T.
errShare
errSave
The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease
err2013-03-30
err0
errOAAI
errAntonietta Fava; Domenico Pirritano; Massimiliano Plastino; Dario Cristiano; Giovanna Puccio; Carmen Colica; Caterina Ermio; Matteo De Bartolo; Gaetano Mauro; Domenico Bosco
errShare
errSave
researcher View more